88 related articles for article (PubMed ID: 36457504)
1. Integrated network pharmacology and experimental verification to investigate the mechanisms of YYFZBJS against colorectal cancer
Li J; Zhou F; Shang L; Liu N; Liu Y; Zhang M; Wang S; Yang S
Front Oncol; 2022; 12():961653. PubMed ID: 36457504
[TBL] [Abstract][Full Text] [Related]
2. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
Comput Biol Med; 2023 Nov; 166():107432. PubMed ID: 37729701
[TBL] [Abstract][Full Text] [Related]
3. YYFZBJS inhibits colorectal tumorigenesis by enhancing Tregs-induced immunosuppression through HIF-1α mediated hypoxia in vivo and in vitro.
Zhang Y; Chai N; Wei Z; Li Z; Zhang L; Zhang M; Ren J; Xu R; Pang X; Zhang B; Tang Q; Sui H
Phytomedicine; 2022 Apr; 98():153917. PubMed ID: 35093671
[TBL] [Abstract][Full Text] [Related]
4. Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells.
Gao Q; Li L; Zhang QM; Sheng QS; Zhang JL; Jin LJ; Shang RY
Chin J Integr Med; 2024 Jan; 30(1):25-33. PubMed ID: 37750986
[TBL] [Abstract][Full Text] [Related]
5. The Role of Emodin in the Treatment of Bladder Cancer based on Network Pharmacology and Experimental Verification.
Liu F; Li J; Zhou B; Shen Y; Tang J; Han J; Chen C; Shao K; Chen H; Yuan L
Comb Chem High Throughput Screen; 2024 Mar; ():. PubMed ID: 38504574
[TBL] [Abstract][Full Text] [Related]
6. Herba Patriniae and its component Isovitexin show anti-colorectal cancer effects by inducing apoptosis and cell-cycle arrest via p53 activation.
Li J; Shang L; Zhou F; Wang S; Liu N; Zhou M; Lin Q; Zhang M; Cai Y; Chen G; Yang S
Biomed Pharmacother; 2023 Dec; 168():115690. PubMed ID: 37939611
[TBL] [Abstract][Full Text] [Related]
7. Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through the ESR2/PI3K/AKT Signalling Pathway.
Luo F; Tang Y; Zheng L; Yang Y; Gao H; Tian S; Chen H; Tang C; Tang S; Man Q; Wu Y
Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38256877
[TBL] [Abstract][Full Text] [Related]
8. Integrating Network Pharmacology and In Vitro Experimental Verification Revealing Bushenhuoxue Recipe Against Intrauterine Adhesions via PI3K-AKT Signaling Pathway.
Wang L; Zhuang L; Lu Y; Jia J; Chen C; Zhang Y; Hong Z; Wang X
Biochem Genet; 2024 Mar; ():. PubMed ID: 38502457
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the effect and mechanism of Scutellaria barbata D. Don in the treatment of ovarian cancer based on network pharmacology and in vitro experimental verification.
Zhang J; Qi C; Li H; Ding C; Wang L; Wu H; Dai W; Wang C
Medicine (Baltimore); 2023 Dec; 102(51):e36656. PubMed ID: 38134066
[TBL] [Abstract][Full Text] [Related]
10. Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of Cnidii Fructus in Treating Colorectal Cancer.
Wei Z; Zhang X; Peng A; Liu C; Zhang Y; Duan X; Pang J
Comb Chem High Throughput Screen; 2023 Oct; ():. PubMed ID: 37861043
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and bioinformatics to identify the molecular mechanisms of Gleditsiae Spina against colorectal cancer.
Wu Y; Luo J; Xu B
Curr Res Toxicol; 2023; 5():100139. PubMed ID: 38059131
[TBL] [Abstract][Full Text] [Related]
12. Anticancer Effects of Wild Baicalin on Hepatocellular Carcinoma: Downregulation of AKR1B10 and PI3K/AKT Signaling Pathways.
Sun L; Chen W; Zhao P; Zhao B; Lei G; Han L; Zhang Y
Cancer Manag Res; 2024; 16():477-489. PubMed ID: 38800664
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol mediated the proliferation and apoptosis of gastric cancer cells by modulating the PI3K/Akt/P53 signaling pathway.
Dong Q; Zheng A; Zhai H; Zhang T
Biochem Biophys Res Commun; 2024 May; 723():150186. PubMed ID: 38830298
[TBL] [Abstract][Full Text] [Related]
14. Wortmannin Inhibits Cell Growth and Induces Apoptosis in Colorectal Cancer Cells by Suppressing the PI3K/AKT Pathway.
Bani N; Rahmani F; Shakour N; Amerizadeh F; Khalili-Tanha G; Khazaei M; Hassanian SM; Kerachian MA; Abbaszadegan MR; Mojarad M; Hadizadeh F; Ferns GA; Avan A
Anticancer Agents Med Chem; 2024 Apr; ():. PubMed ID: 38584531
[TBL] [Abstract][Full Text] [Related]
15. Loureirin B inhibits Cervical Cancer Development by Blocking PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation.
Hong Y; Sun X; Lu L
Appl Biochem Biotechnol; 2024 Jun; ():. PubMed ID: 38888697
[TBL] [Abstract][Full Text] [Related]
16. Investigating the pharmacological mechanism of Zhengyuan jiaonang for treating colorectal cancer via network pharmacology analysis and experimental verification.
Deng H; Liu S; Li D; Wang W; Ye L; Xu S; Wang X; Li Y
J Ethnopharmacol; 2024 Mar; 322():117607. PubMed ID: 38110132
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of coptisine derivative EHLJ7 on colorectal cancer by inhibiting PI3K/AKT pathway.
Chai C; Tang X; Chi X; Li X; Zhang H; Wu L
Cell Signal; 2024 Apr; 116():111053. PubMed ID: 38224723
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanism Analysis of the Effect of Hederagenin Combined with L-OHP on Chemosensitivity of AGS/L-OHP Based on Network Pharmacology.
Tang H; Wang C; Xing C; Liang G; Guo C; Liu X; Li Y; Zhang M
Curr Comput Aided Drug Des; 2024 Jan; ():. PubMed ID: 38243937
[TBL] [Abstract][Full Text] [Related]
19. Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K/Akt pathway.
Zhang C; Cao Y; Zuo Y; Cheng H; Liu C; Xia X; Ren B; Deng Y; Wang M; Lu J
Front Pharmacol; 2023; 14():1149478. PubMed ID: 37056992
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology-based approach to investigate the molecular targets of essential oil obtained from lavender for treating breast cancer.
Maitisha G; Zhou J; Zhao Y; Han S; Zhao Y; Abliz A; Liu G
Heliyon; 2023 Nov; 9(11):e21759. PubMed ID: 38034788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
